Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 6.39 USD 6.15%
Market Cap: 943m USD
Have any thoughts about
Adaptive Biotechnologies Corp?
Write Note

Balance Sheet

Balance Sheet Decomposition
Adaptive Biotechnologies Corp

Current Assets 308.3m
Cash & Short-Term Investments 243.3m
Receivables 40.8m
Other Current Assets 24.2m
Non-Current Assets 250.2m
Long-Term Investments 23.9m
PP&E 97.8m
Intangibles 122.8m
Other Non-Current Assets 5.6m
Current Liabilities 87.6m
Accounts Payable 7.4m
Accrued Liabilities 28.4m
Other Current Liabilities 51.9m
Non-Current Liabilities 247.1m
Long-Term Debt 132.7m
Other Non-Current Liabilities 114.4m

Balance Sheet
Adaptive Biotechnologies Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
85
55
97
123
139
90
65
Cash Equivalents
85
55
97
123
139
90
65
Short-Term Investments
107
110
480
565
214
408
281
Total Receivables
6
5
13
10
17
40
38
Accounts Receivables
6
5
13
10
17
40
38
Other Receivables
0
0
0
0
0
0
0
Inventory
5
8
9
14
19
15
14
Other Current Assets
3
3
14
15
13
9
11
Total Current Assets
205
181
613
727
403
562
410
PP&E Net
14
19
60
139
173
164
120
PP&E Gross
14
19
60
139
173
164
120
Accumulated Depreciation
9
13
18
24
36
54
73
Intangible Assets
15
14
12
10
9
7
5
Goodwill
119
119
119
119
119
119
119
Long-Term Investments
9
0
105
119
217
0
0
Other Long-Term Assets
0
0
3
3
3
5
7
Other Assets
119
119
119
119
119
119
119
Total Assets
363
N/A
333
-8%
912
+174%
1 116
+22%
923
-17%
857
-7%
661
-23%
Liabilities
Accounts Payable
2
2
5
3
3
8
8
Accrued Liabilities
4
7
10
27
30
37
32
Short-Term Debt
0
0
0
0
0
0
0
Other Current Liabilities
15
14
63
75
81
64
49
Total Current Liabilities
21
23
78
105
114
110
88
Long-Term Debt
0
0
37
0
0
0
131
Minority Interest
0
0
0
0
0
0
0
Other Liabilities
4
7
226
268
205
283
134
Total Liabilities
26
N/A
30
+16%
341
+1 041%
373
+9%
319
-14%
393
+23%
353
-10%
Equity
Common Stock
561
561
0
0
0
0
0
Retained Earnings
249
296
366
512
719
919
1 144
Additional Paid In Capital
25
38
936
1 254
1 324
1 387
1 453
Other Equity
0
0
1
1
1
4
0
Total Equity
337
N/A
303
-10%
571
+89%
743
+30%
604
-19%
464
-23%
308
-34%
Total Liabilities & Equity
363
N/A
333
-8%
912
+174%
1 116
+22%
923
-17%
857
-7%
661
-23%
Shares Outstanding
Common Shares Outstanding
119
119
125
138
141
143
145

See Also

Discover More